(WRD) WeRide American Depositary - NASDAQ
Sector: Technology | Industry: Software - Application | Exchange: NASDAQ (USA) | Market Cap: 2.036m USD | Total Return: -18.3% in 12m
Avg Turnover: 19.8M
Rev. Trend: 77.3%
Warnings
Share dilution 22.3% YoY
Interest Coverage Ratio -207.5 is critical
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
WeRide Inc. (WRD) is a Guangzhou-based technology firm specializing in autonomous driving solutions across the mobility, logistics, and sanitation sectors. The company develops and deploys a diverse fleet of autonomous vehicles, including robotaxis, robobuses, robovans, and robosweepers, alongside a proprietary ride-hailing application and advanced driver-assistance systems (ADAS).
Operating within the capital-intensive autonomous driving industry, WeRide utilizes a Level 4 automation focus, aiming for high-order vehicle autonomy that requires minimal human intervention. The business model involves both direct hardware deployment and software-as-a-service (SaaS) integration for commercial logistics and municipal sanitation fleets. The company is currently expanding its geographic footprint through strategic alliances beyond China, including initiatives in the European market.
For a more granular look at the companys valuation metrics and competitive positioning, consider reviewing the latest data on ValueRay. This summary reflects WeRides position as a diversified player in the global shift toward automated transport infrastructure.
- Commercialization scale of Robotaxi and Robobus fleets drives top-line revenue growth
- Expansion into international markets reduces heavy dependency on Chinese regulatory approval
- Research and development spending on L4 autonomous technology impacts short-term profitability
- Strategic partnerships with automotive OEMs determine mass production and deployment capabilities
- Geopolitical tensions and US-China trade policies influence investor sentiment and liquidity
| Net Income: -1.65b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.19 > 0.02 and ΔFCF/TA -10.06 > 1.0 |
| NWC/Revenue: 876.5% < 20% (prev 1.76k%; Δ -878.7% < -1%) |
| CFO/TA -0.16 > 3% & CFO -1.32b > Net Income -1.65b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 7.63 > 1.5 & < 3 |
| Outstanding Shares: last quarter (341.4m) vs 12m ago 22.34% < -2% |
| Gross Margin: 30.45% > 18% (prev 29.44%; Δ 1.00% > 0.5%) |
| Asset Turnover: 9.35% > 50% (prev 4.96%; Δ 4.39% > 0%) |
| Interest Coverage Ratio: -207.5 > 6 (EBIT TTM -1.84b / Interest Expense TTM 8.88m) |
| A: 0.78 (Total Current Assets 7.28b - Total Current Liabilities 953.9m) / Total Assets 8.12b |
| B: -1.27 (Retained Earnings -10.3b / Total Assets 8.12b) |
| C: -0.24 (EBIT TTM -1.84b / Avg Total Assets 7.71b) |
| D: 7.09 (Book Value of Equity 7.11b / Total Liabilities 1.00b) |
| Altman-Z'' = 6.82 = AAA |
| DSRI: 0.48 (Receivables 459.7m/476.4m, Revenue 721.3m/362.4m) |
| GMI: 0.97 (GM 29.44% / 30.45%) |
| AQI: 1.89 (AQ_t 0.04 / AQ_t-1 0.02) |
| SGI: 1.99 (Revenue 721.3m / 362.4m) |
| TATA: -0.04 (NI -1.65b - CFO -1.32b) / TA 8.12b) |
| Beneish M = -2.25 (Cap -4..+1) = BBB |
As of June 19, 2026, the stock is trading at USD 6.31 with a total of 2,765,698 shares traded.
Over the past week, the price has changed by +3.44%,
over one month by -9.99%,
over three months by -2.02% and
over the past year by -18.26%.
WeRide American Depositary has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy WRD.
- StrongBuy: 1
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 14.2 | 125.5% |
Market Cap CNY = 13.8b (2.04b USD * 6.7587 USD.CNY)
P/S = 2.8038
P/B = 1.9315
Revenue TTM = 721.3m CNY
EBIT TTM = -1.84b CNY
EBITDA TTM = -1.68b CNY
Long Term Debt = 20.9m CNY (estimated: total debt 339.6m - short term 318.6m)
Short Term Debt = 318.6m CNY (from shortTermDebt, last quarter)
Debt = 386.1m CNY (from shortLongTermDebtTotal, last quarter) + Leases 46.6m
Net Debt = -5.80b CNY (calculated: Debt 386.1m - CCE 6.19b)
Enterprise Value = 7.96b CNY (13.8b + Debt 386.1m - CCE 6.19b)
Interest Coverage Ratio = -207.5 (Ebit TTM -1.84b / Interest Expense TTM 8.88m)
EV/FCF = -5.07x (Enterprise Value 7.96b / FCF TTM -1.57b)
FCF Yield = -19.72% (FCF TTM -1.57b / Enterprise Value 7.96b)
FCF Margin = -217.7% (FCF TTM -1.57b / Revenue TTM 721.3m)
Net Margin = -228.4% (Net Income TTM -1.65b / Revenue TTM 721.3m)
Gross Margin = 30.45% ((Revenue TTM 721.3m - Cost of Revenue TTM 501.7m) / Revenue TTM)
Gross Margin QoQ = 34.70% (prev 28.49%)
Tobins Q-Ratio = 0.98 (Enterprise Value 7.96b / Total Assets 8.12b)
Interest Expense / Debt = 2.30% (Interest Expense 8.88m / Debt 386.1m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -1.46b (EBIT -1.84b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 7.63 (Total Current Assets 7.28b / Total Current Liabilities 953.9m)
Debt / Equity = 0.05 (Debt 386.1m / totalStockholderEquity, last quarter 7.11b)
Debt / EBITDA = 3.46 (negative EBITDA) (Net Debt -5.80b / EBITDA -1.68b)
Debt / FCF = 3.70 (negative FCF - burning cash) (Net Debt -5.80b / FCF TTM -1.57b)
Total Stockholder Equity = 6.92b (last 4 quarters mean from totalStockholderEquity)
RoA = -21.35% (Net Income -1.65b / Total Assets 8.12b)
RoE = -23.79% (Net Income TTM -1.65b / Total Stockholder Equity 6.92b)
RoCE = -26.53% (EBIT -1.84b / Capital Employed (Equity 6.92b + L.T.Debt 20.9m))
RoIC = -19.55% (negative operating profit) (NOPAT -1.46b / Invested Capital 7.45b)
WACC = 18.15% (E(13.8b)/V(14.1b) * Re(18.61%) + D(386.1m)/V(14.1b) * Rd(2.30%) * (1-Tc(0.21)))
Discount Rate = 18.61% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 95.45 | Cagr: 11.35%
[DCF] Fair Price = unknown (Cash Flow -1.57b)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 77.27 | Revenue CAGR: 28.73% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.74 | Chg30d=-80.25% | Revisions=N/A | Analysts=2
EPS next Quarter (2026-09-30): EPS=-0.62 | Chg30d=-97.63% | Revisions=N/A | Analysts=2
EPS current Year (2026-12-31): EPS=-3.97 | Chg30d=+12.95% | Revisions=+20% | GrowthEPS=-194.6% | GrowthRev=+58.9%
EPS next Year (2027-12-31): EPS=-3.16 | Chg30d=-7.63% | Revisions=N/A | GrowthEPS=+20.2% | GrowthRev=+103.2%
[Analyst] Revisions Ratio: +20%